Astec Lifesciences Ltd
As of 16 Oct 2026, Astec Lifesciences is in Stage 1 — basing, not yet in an uptrend, in week 2 (since 5 Oct 2026). It closed at ₹710, 22.7% below its 52-week high and above its 200-day average, which is falling. In Materials, 34.1% of stocks are in Stage 2.
Astec LifeSciences Limited, together with its subsidiaries, manufactures and sells agrochemical active ingredients and pharmaceutical intermediates in India. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is ASTEC early, or has it already run? Pro answers that for every NSE stock, after every close.
About this companyMaterials· Fertilizers & Agro Chemicals
Astec LifeSciences Limited, together with its subsidiaries, manufactures and sells agrochemical active ingredients and pharmaceutical intermediates in India. The company provides triazole fungicides for use in field crops; foliar treatment for the control of scab, powdery mildew, shot-hole, blossom blight, and rust; seed treatment for the control of seed and soil-borne diseases in cotton and maize, as well as grains, such as barley, rice, and wheat; post-harvest drench; and food additive and wood preservative. It also provides herbicides, insecticides, and specialty chemical products. The company also exports its products. The company was incorporated in 1994 and is based in Mumbai, India. Astec LifeSciences Limited is a subsidiary of Godrej Agrovet Limited.
Visit company website →All analytics based on EOD data. Data as of 2026-10-16. Past data patterns are not indicative of future results. This page is a data analytics tool only.